Clinical phenotype and gene expression profile in Crohn's disease

被引:17
作者
Csillag, Claudio
Nielsen, Ole Haagen
Borup, Rehannah
Nielsen, Finn Cilius
Olsen, Jorgen
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Gastroenterol C, DK-2730 Herlev, Denmark
[2] Rigshosp, Dept Clin Biochem, Core Unit Microarray Anal, DK-2100 Copenhagen, Denmark
[3] Univ Copenhagen, Dept Med Biochem & Genet, Copenhagen, Denmark
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2007年 / 292卷 / 01期
关键词
clinical presentation; inflammatory bowel disease; microarray;
D O I
10.1152/ajpgi.00321.2006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clinical phenotype and gene expression profile in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 292: G298-G304, 2007. First published September 7, 2006; doi:10.1152/ajpgi.00321.2006.-The clinical course varies significantly among patients with Crohn's disease (CD). This study investigated whether gene expression profiles generated by DNA microarray technology might predict disease progression. Biopsies from the descending colon were obtained colonoscopically from 40 CD patients. Gene profiling analyses were performed using a Human Genome U133 Plus 2.0 GeneChip Array, and summarization into a single expression measure for each probe set was performed using the robust multiple array procedure. Principal component analysis demonstrated that three components explain two-thirds of the total variation. The most important parameters for the determination of the colonic gene expression patterns were the presence of disease (CD) and presence of inflammation. Superimposition of clinical phenotype data revealed a grouping of the samples from patients with stenosis toward negative values on the axis of the second principal component. The functional annotation analysis suggested that the expression of genes involved in intracellular transport and cytoskeletal organization might influence the development of stenosis. In conclusion, even though most variation in the colonic gene expression patterns is due to presence or absence of CD and inflammation status, the development of stenosis is a parameter that affects colonic gene expression to some extent.
引用
收藏
页码:G298 / G304
页数:7
相关论文
共 42 条
[1]
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease [J].
Abreu, MT ;
Taylor, KD ;
Lin, YC ;
Hang, T ;
Gaiennie, J ;
Landers, CJ ;
Vasiliauskas, EA ;
Kam, LY ;
Rojany, M ;
Papadakis, KA ;
Rotter, JI ;
Targan, SR ;
Yang, HY .
GASTROENTEROLOGY, 2002, 123 (03) :679-688
[2]
The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[3]
Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence [J].
Alvarez-Lobos, M ;
Arostegui, JI ;
Sans, M ;
Tassies, D ;
Plaza, S ;
Delgado, S ;
Lacy, AM ;
Pique, JM ;
Yagüe, J ;
Panés, J .
ANNALS OF SURGERY, 2005, 242 (05) :693-700
[4]
The genetics of inflammatory bowel disease [J].
Bonen, DK ;
Cho, JH .
GASTROENTEROLOGY, 2003, 124 (02) :521-536
[5]
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype [J].
Brand, S ;
Hofbauer, K ;
Dambacher, J ;
Schnitzler, F ;
Staudinger, T ;
Pfennig, S ;
Seiderer, J ;
Tillack, C ;
Konrad, A ;
Göke, B ;
Ochsenkühn, T ;
Lohse, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) :99-106
[6]
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity [J].
Brant, SR ;
Panhuysen, CIM ;
Bailey-Wilson, JE ;
Rohal, PM ;
Lee, S ;
Mann, J ;
Ravenhill, G ;
Kirschner, BS ;
Hanauer, SB ;
Cho, JH ;
Bayless, TM .
GASTROENTEROLOGY, 2000, 119 (06) :1483-1490
[7]
CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
[8]
CSILLAG C, IN PRESS SCAND J GAS
[9]
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease [J].
Cuthbert, AP ;
Fisher, SA ;
Mirza, MM ;
King, K ;
Hampe, J ;
Croucher, PJP ;
Mascheretti, S ;
Sanderson, J ;
Forbes, A ;
Mansfield, J ;
Schreiber, S ;
Lewis, CM ;
Mathew, CG .
GASTROENTEROLOGY, 2002, 122 (04) :867-874
[10]
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease [J].
Darfeuille-Michaud, A ;
Boudeau, J ;
Bulois, P ;
Neut, C ;
Glasser, AL ;
Barnich, N ;
Bringer, MA ;
Swidsinski, A ;
Beaugerie, L ;
Colombel, JF .
GASTROENTEROLOGY, 2004, 127 (02) :412-421